Treatment with Soliris (eculizumab) leads to significant benefits in people with treatment-resistant generalized myasthenia gravis (gMG), including those with…
Treatments promoting the formation of acetylcholine receptor (AChR) clusters could represent a new therapeutic approach for people with MuSK-autoantibody…
Current patient- and physician-reported measures of disease severity and clinical response effectively reflect rapid improvements associated with plasma exchange in…
A microRNA called miR-143, which blocks a molecule involved in the development and severity of myasthenia gravis, may be…
Weekly infusions of Rituxan (rituximab) for four consecutive weeks followed by a monthly infusion for two months may be more effective…
Quality of life among myasthenia gravis (MG) patients is worse in women than men, but removing the thymus in women…
Get regular updates to your inbox.
